About
Technology
Issues
FAQ
Links
Official Page
Bosutinib in the real‐life treatment of chronic myeloid leukemia patients aged >65 years resistant/intolerant to previous tyrosine‐kinase inhibitors
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.